Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue:
Revenues	$ 62,839	$ 52,904	$ 39,986
Operating costs and expenses:
Research and development	221,226	206,922	111,340
Acquired in-process research and development	12,272	24,208	42,992
Selling, general and administrative	182,337	196,856	116,179
Intangible amortization	4,325	4,140	4,053
(Decrease) increase on contingent consideration	(75,400)	9,198
Loss on impairment of intangible assets	124,190
Legal settlements, net	64,752
Total operating costs and expenses	567,154	454,355	284,504
Loss from operations	(504,315)	(401,451)	(244,518)
Gain (loss) on derivative liabilities	7,316	(300)	6,600
Loss on marketable and equity investments	(83,919)	(15,013)
Gain (loss) on debt extinguishment	27,009	(6,695)	(51,939)
Scilex Notes principal increase		(28,000)
Interest expense, net	(8,574)	(10,224)	(20,157)
Other income (loss)	736	(845)	(566)
Loss before income tax	(561,747)	(462,528)	(310,580)
Income tax benefit	(2,416)	(33,516)	(2,014)
Loss on equity method investments	(18,426)	(126)	(5,844)
Net loss	(577,757)	(429,138)	(314,410)
Net loss attributable to noncontrolling interests	(4,914)	(813)	(15,949)
Net loss attributable to Sorrento	$ (572,843)	$ (428,325)	$ (298,461)
Net loss per share - basic per share attributable to Sorrento	$ (1.37)	$ (1.45)	$ (1.30)
Net loss per share - diluted per share attributable to Sorrento	$ (1.37)	$ (1.45)	$ (1.30)
Weighted-average shares outstanding during period - basic shares attributable to Sorrento (in shares)	419,315	294,774	229,823
Weighted-average shares outstanding during period - diluted shares attributable to Sorrento (in shares)	419,315	294,774	229,823
Product
Revenue:
Revenues	$ 44,996	$ 28,735	$ 26,628
Operating costs and expenses:
Cost of product sold and services	28,913	3,851	2,149
Service
Revenue:
Revenues	17,843	24,169	13,358
Operating costs and expenses:
Cost of product sold and services	$ 4,539	$ 9,180	$ 7,791